Arcellx Patents – Key Insights and Stats

Arcellx has a total of 72 patents globally, out of which 20 have been granted. Of these 72 patents, more than 93% patents are active. United States of America is where Arcellx has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D center and is also the origin country of Arcellx. Arcellx’s initial public offering (IPO) has been declared for the month of February 2022 and the anticipation is building for its impending listing.

Arcellx was founded in the year 2014 by David Hilbert. Company is doing business in clinical-stage biopharmaceutical As of February 2022, Arcellx has a market valuation of $570.24 million.

Do read about some of the most popular patents of Arcellx which have been covered by us in this article and also you can find Arcellx’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Arcellx’s patent portfolio.

How many patents does the founder and the CEO of Arcellx have?

The founder and CEO, Sashi Narahari has 32 patents.

How many patents does Arcellx have?

Arcellx has a total of 72 patents globally. These patents belong to 6 unique patent families. Out of 72 patents, 67 patents are active.

How many Arcellx patents are Alive/Dead?

Worldwide Patents

Arcellx Worldwide Legal Trends

Patent Families

Arcellx Patent Portfolio

How Many Patents did Arcellx File Every Year?

Arcellx Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantArcellx Applications FiledArcellx Patents Granted
201630
20174
201824
2019
202054
2021916

How Many Patents did Arcellx File in Different Countries?

Arcellx Worldwide Filing in Top 10 Countries

Countries in which Arcellx Filed Patents

CountryPatents
United States Of America9
Japan5
Europe5
Hong Kong (S.A.R.)5
Australia4
Singapore4
Canada4
Israel4
Brazil3
Philippines3
India3
Korea (South)3
Denmark2
Mexico2
Spain1
Slovenia1
Lithuania1
Serbia1
Indonesia1
New Zealand1
South Africa1
Croatia1
Germany1
Poland1
Hungary1
Portugal1

Where are Research Centers of Arcellx Patents Located?

Arcellx R&D Centers

10 Best Arcellx Patents

WO2016164308A1 is the most popular patent in the Arcellx portfolio. It has received 16 citations so far from companies like Subdomain and L.E.A.F. Holdings Group

Below is the list of 10 most cited patents of Arcellx:

Publication NumberCitation Count
WO2016164308A116
WO2016164305A112
WO2019099440A15
US10662248B22
US10647775B22
US20180209983A12
US20210002381A11
KR1020180012747A1
US20210401891A10
US20210403517A10

What Percentage of Arcellx US Patent Applications were Granted?

Arcellx (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75.0%.

Below are the key stats of Arcellx patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Arcellx?

Law FirmTotal ApplicationSuccess Rate
Nixon & Vanderhye Pc775.00%

List of Arcellx Patents

Arcellx PatentsTitle
US20210401891A1D-domain containing polypeptides and uses thereof
US20210403517A1D-domain containing polypeptides and uses thereof
US20210230288A1De novo binding domain containing polypeptides and uses thereof
US11008397B2De novo binding domain containing polypeptides and uses thereof
US20210023133A1Multifunctional immune cell therapies
US20210002381A1De novo binding domain containing polypeptides and uses thereof
US10662248B2De novo binding domain containing polypeptides and uses thereof
US10647775B2De novo binding domain containing polypeptides and uses thereof
US20180209983A1De novo binding domain containing polypeptides and uses thereof
EP3710034A4Multifunctional immune cell therapies
EP3903804A1De novo binding domain containing polypeptides and uses thereof
EP3710067A4D-domain containing polypeptides and uses thereof
EP3280433B1De novo binding domain containing polypeptides and uses thereof
EP3280432B8De novo binding domain containing polypeptides and uses thereof
CA3082410A1Multifunctional immune cell therapies
CA3082406A1D-domain containing polypeptides and uses thereof
CA2981616A1De novo binding domain containing polypeptides and uses thereof
CA2981711A1De novo binding domain containing polypeptides and uses thereof
WO2019099433A3D-domain containing polypeptides and uses thereof
WO2019099440A1Multifunctional immune cell therapies
WO2016164308A1De novo binding domain containing polypeptides and uses thereof
WO2016164305A1De novo binding domain containing polypeptides and uses thereof
AU2021200810A1De novo binding domain containing polypeptides and uses thereof
AU2016246426B2De novo binding domain containing polypeptides and uses thereof
AU2018369639A1D-domain containing polypeptides and uses thereof
AU2018368431A1Multifunctional immune cell therapies
JP2021503006A5Multifunctional immune cell therapy
JP2021502826A5D domain-containing polypeptide and its use
HK1249422ADe novo binding domain containing polypeptides and uses thereof
HK1249422A1De novo binding domain containing polypeptides and uses thereof
MX387517BPolipeptides containing Novo union domains and use of them.
DK3280433T3de novo-binding domain containing polypeptides and uses thereof
ZA201706875BDe novo binding domain containing polypeptides and uses thereof
ES2866202T3polypeptides containing Novo union domains and use of them
SI3280432T1De novo binding domain containing polypeptides and uses thereof
HUE054435T2De novo binding domain containing polypeptides and uses thereof
PL3280432T3De novo binding domain containing polypeptides and uses thereof
DE602016063756T2DE-Novo binding domain with polypeptides and uses thereof
JP2021106605ANovel binding domain-containing polypeptide and use thereof
RS61907B1De novo binding domain containing polypeptides and uses thereof
IL282704D0De novo binding domain containing polypeptides and uses thereof
HRP20210498T1De novo binding domain containing polypeptides and uses thereof
LT3280432TDe novo binding domain containing polypeptides and uses thereof
JP6873101B2Novel binding domain-containing polypeptide and its use
JP6871232B2Novel binding domain-containing polypeptide and its use
DK3280432T3Polypeptides containing the Novo binding domains and applications thereof
HK40034396AD-domain containing polypeptides and uses thereof
PT3280432TDe novo binding domain containing polypeptides and uses thereof
HK40033094AMultifunctional immune cell therapies
NZ774195ADe novo binding domain containing polypeptides and uses thereof
IDP000075612Bdomain binder de novo containing polypeptides and its use
MX2020004933Apolypeptides containing domains d and their uses
PH12020550240A1D-domain containing polypeptides and uses thereof
PH12020550242A1Multifunctional immune cell therapies
BR112020008939A2Multifunctional immune cell therapies
BR112020009136A2polypeptides containing domain d and uses of the same
IN202027024691AMultifunctional immune cell therapies
IN202027024698AD-domain containing polypeptides and uses thereof
SG10202007987QADe novo binding domain containing polypeptides and uses thereof
SG11201708257UBDe novo binding domain containing polypeptides and uses thereof
KR1020200096769Ad-domain containing polypeptides and uses thereof
KR1020200087176AMultifunctional immune cell therapy
IL274652AD-domain containing polypeptides and uses thereof
IL274677AMultifunctional immune cell therapies
SG11202003169XAD-domain containing polypeptides and uses thereof
SG11202003168WAMultifunctional immune cell therapies
HK1249421ADe novo binding domain containing polypeptides and uses thereof
BR112017021308A2Polipeptídeos containing domain of connection of form and use of the same
PH12017501834A1De novo binding domain containing polypeptides and uses thereof
KR1020180012747ADe novo binding domain containing polypeptides and uses thereof
IL254907ADe novo binding domain containing polypeptides and uses thereof
IN201717036277ADe novo binding domain containing polypeptides and uses thereof
Updated on February 3, 2022

Was this article helpful?

Leave a Comment